ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BHZPJ569
Stock Name / FundiShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity Type
Entity LEI 549300ZP07LMR36K1T02
ETF TickerEGMW(GBP) LSE
ETF TickerEDMWx(GBP) CXE
ETF TickerENWD.MI(EUR) CXE
ETF TickerENWD(EUR) ETF Plus
ETF TickerEGMW.L(GBP) LSE

Holdings detail for LLY

Stock NameEli Lilly and Company
TickerLLY(EUR) F
TYPECommon Stock
CountryGermany
ISINUS5324571083
LEIFRDRIPF3EKNDJ2CQJL29

Show aggregate LLY holdings

News associated with LLY

Notable Friday Option Activity: AMD, LLY, BKNG
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Advanced Micro Devices Inc (Symbol: AMD), where a total volume of 570,924 contracts has been traded thus far today, a contract volume which is representative of a - 2025-09-19 14:45:00
Boost Your Portfolio With These Top-Ranked ETFs
With the Fed's first 2025 rate cut and upgraded growth outlook, ETFs in tech, financials, industrials and health care could benefit from momentum. - 2025-09-19 13:03:00
3 Dividend Growth Stocks You Can Buy and Forget About
Key PointsThese stocks offer seemingly low yields of less than 1%. - 2025-09-18 05:50:00
JPMorgan Chase & Co. Has Lowered Expectations for Eli Lilly and Company (NYSE:LLY) Stock Price
Eli Lilly and Company (NYSE:LLY – Get Free Report) had its price objective decreased by JPMorgan Chase & Co. from $1,100.00 to $1,050.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 38.09% from the […] - 2025-09-18 02:56:56
Lilly's Orforglipron Achieves Significant Weight Loss In Phase 3 Trial
(RTTNews) - Eli Lilly and Co. (LLY) announced detailed results from its Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of orforglipron—an investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist—in adults with obesity, or those overweight with a weight-re - 2025-09-17 00:35:16
XLV, LLY, TMO, PFE: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $308.0 million dollar inflow -- that's a 0.9% increase we - 2025-09-16 11:47:58
S&P 500 Analyst Moves: LLY
The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Eli Lilly is now the #61 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each - 2025-09-15 14:35:56
Why Novo Nordisk Stock Popped Today
Key PointsLondon's Financial Times highlights improved weight loss from taking more Ozempic. - 2025-09-15 12:34:46
Sen. John Boozman Buys Eli Lilly and Company (NYSE:LLY) Stock
Senator John Boozman (R-Arkansas) recently bought shares of Eli Lilly and Company (NYSE:LLY). In a filing disclosed on September 12th, the Senator disclosed that they had bought between $1,001 and $15,000 in Eli Lilly and Company stock on August 11th. Senator John Boozman also recently made the following trade(s): Purchased $1,001 – $15,000 in shares […] - 2025-09-15 03:12:42
3 Monster Stocks to Hold for the Next 5 Years
Key PointsAmazon should improve its profits and margins, based on its cloud computing and AI initiatives. - 2025-09-14 08:45:00
2 Beaten-Down Stocks to Buy and Hold Forever
Key PointsApple and Eli Lilly have impressive long-term track records of returns. - 2025-09-13 08:45:00
2 Monster Stocks to Hold for the Next 5 Years
Key PointsThese stocks have climbed in the triple digits over the past three years. - 2025-09-11 05:20:00
IWB, LLY, ORCL, CVX: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $462.9 million dollar inflow -- that's a 1.1% increase week over week in - 2025-09-08 12:03:03
Down 34%, Should You Buy the Dip on Viking Therapeutics?
Key PointsViking Therapeutics is working on an injectable weight loss drug candidate and one in pill format. - 2025-09-05 05:10:00
The 6 Best Stocks to Buy Right Now in September (2025)!
My list of best stocks to buy has outperformed the broader market indexes by a significant margin. - 2025-09-04 06:00:00
The Problem With Weight Loss Stocks
In this Motley Fool Money episode, Motley Fool analysts Rick Munarriz and Karl Thiel and contributor Jason Hall dig into the problems with weight loss stocks. They also look at some investments that can survive near-term potential volatility as well as give a long-term view of di - 2025-09-03 14:48:00
NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction?
Novo Nordisk's Wegovy shows a stronger reduction in heart risks compared to Eli Lilly's tirzepatide in real-world data from the STEER study. - 2025-09-01 11:54:00
The Zacks Analyst Blog Highlights Lilly, Oracle, Procter & Gamble and Comstock Holding Companies
Zacks spotlights Eli Lilly, Oracle, Procter & Gamble, and microcap Comstock Holding, with pharma and staples facing pressure while Oracle and Comstock show momentum. - 2025-08-29 13:58:00
Nvidia's $46.7 Billion Quarter Shows the AI Trade Is Alive and Well -- With Caveats
Key PointsWhile earnings were up 56%, the company's data center revenue dropped 1% sequentially. - 2025-08-29 05:45:00
Top Stock Reports for Eli Lilly, Oracle & Procter & Gamble
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly, Oracle, and Procter & Gamble, as well as a micro-cap stock, Comstock. - 2025-08-28 18:59:00
2 Growth Stocks That Could Be Worth $1 Trillion in 5 Years
Key PointsEli Lilly's work in weight management should help it surpass some industry sales records. - 2025-08-28 10:45:00
2 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade
Key PointsDividend-paying stocks tend to outperform non-dividend-paying stocks by a mile. - 2025-08-28 04:26:00
As the Market Rotates, This Healthcare ETF Is Leading the Way
Over the past month, the market has undergone a rotation that’s seen tech sell-off and defensive sectors like healthcare reap the rewards. The jury remains out on whether this shift indicates a more inclusive rally or if it should raise questions about the bull market’s footing. - 2025-08-26 10:35:00
When AI Execs Say the Market Looks Bubbly
In this podcast, Motley Fool contributors Tyler Crowe, Lou Whiteman, and Rachel Warren discuss: - 2025-08-25 14:47:00
Eli Lilly and Company (NYSE:LLY) and Innoviva (NASDAQ:INVA) Financial Analysis
Eli Lilly and Company (NYSE:LLY – Get Free Report) and Innoviva (NASDAQ:INVA – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings. Institutional & Insider Ownership 82.5% of Eli […] - 2025-08-25 04:38:49
The S&P 500 Hasn't Yielded This Little Since the Dot-Com Bubble. Here's What Investors Can Do.
Key PointsThe S&P 500's rising yield is similar to what happened before the dot-com bubble burst. - 2025-08-24 15:23:00
The Best Stocks to Invest $50,000 in Right Now
Key PointsIf you have a lump sum of money, look for long-term performance and stability. - 2025-08-24 05:32:00
If I Could Only Buy 1 S&P 500 Stock From Each Sector for the Rest of 2025, I'd Go With These 11 Dividend Stocks
Key PointsSome stock market sectors significantly impact the S&P 500, whereas others barely make a dent. - 2025-08-23 19:05:00
Is the Vanguard Mega Cap ETF the Simplest Way to Invest in the Top S&P 500 Stocks?
Key PointsThe fund targets the 37% largest S&P 500 components by market cap. - 2025-08-23 17:05:00
Warren Buffett Makes a Big Buy
In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rick Munarriz discuss: - 2025-08-22 17:55:00

iShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP LLY holdings

DateNumber of LLY Shares HeldBase Market Value of LLY SharesLocal Market Value of LLY SharesChange in LLY Shares HeldChange in LLY Base ValueCurrent Price per LLY Share HeldPrevious Price per LLY Share Held
2025-11-27 (Thursday)68,861USD 76,045,957USD 76,045,9570USD 0 USD 1104.34 USD 1104.34
2025-11-26 (Wednesday)68,861USD 76,045,957LLY holding decreased by -385621USD 76,045,9570USD -385,621 USD 1104.34 USD 1109.94
2025-11-25 (Tuesday)68,861USD 76,431,578LLY holding increased by 2739290USD 76,431,5780USD 2,739,290 USD 1109.94 USD 1070.16
2025-11-24 (Monday)68,861LLY holding increased by 904USD 73,692,288LLY holding increased by 2364621USD 73,692,288904USD 2,364,621 USD 1070.16 USD 1049.6
2025-11-19 (Wednesday)67,957LLY holding increased by 297USD 71,327,667LLY holding increased by 1957222USD 71,327,667297USD 1,957,222 USD 1049.6 USD 1025.28
2025-11-14 (Friday)67,660USD 69,370,445LLY holding increased by 163061USD 69,370,4450USD 163,061 USD 1025.28 USD 1022.87
2025-11-13 (Thursday)67,660LLY holding decreased by -565USD 69,207,384LLY holding increased by 3258370USD 69,207,384-565USD 3,258,370 USD 1022.87 USD 966.64
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LLY by Blackrock for IE00BHZPJ569

Show aggregate share trades of LLY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-24BUY9041,075.7201,049.380 1,052.014EUR 951,021 813.99
2025-11-19BUY2971,055.5501,026.250 1,029.180EUR 305,666 812.87
2025-11-13SELL-5651,032.9501,010.085 1,012.372EUR -571,990 810.85 Loss of -113,858 on sale
2025-11-10BUY339981.990938.830 943.146EUR 319,726 810.10
2025-11-05BUY791955.410908.230 912.948EUR 722,142 808.92
2025-10-27SELL-565826.410826.420 826.419EUR -466,927 808.05 Loss of -10,376 on sale
2025-10-21SELL-339799.570812.990 811.648EUR -275,149 808.01 Loss of -1,234 on sale
2025-10-15BUY2,034826.570830.190 829.828EUR 1,687,870 807.88
2025-10-03SELL-678839.870848.130 847.304EUR -574,472 807.69 Loss of -26,856 on sale
2025-10-02BUY107819.850834.460 832.999EUR 89,131 807.63
2025-10-01BUY1,500825.420833.300 832.512EUR 1,248,768 807.54
2025-09-26BUY321724.540729.000 728.554EUR 233,866 808.65
2025-09-24SELL-41741.850746.940 746.431EUR -30,604 809.51 Profit of 2,586 on sale
2025-07-24BUY1,120805.430810.140 809.669EUR 906,829 811.93
2025-07-23BUY448798.890800.090 799.970EUR 358,387 812.00
2025-07-16BUY112789.800796.040 795.416EUR 89,087 812.86
2025-07-10SELL-530790.650799.490 798.606EUR -423,261 813.44 Profit of 7,861 on sale
2025-07-02BUY224779.280779.840 779.784EUR 174,672 814.69
2025-06-02SELL-448747.120747.370 747.345EUR -334,811 819.41 Profit of 32,285 on sale
2025-05-30BUY2,933737.670745.900 745.077EUR 2,185,311 819.99
2025-05-29SELL-324722.570727.330 726.854EUR -235,501 820.69 Profit of 30,404 on sale
2025-05-28SELL-108719.390729.990 728.930EUR -78,724 821.43 Profit of 9,990 on sale
2025-05-22SELL-1,620715.200722.190 721.491EUR -1,168,815 824.55 Profit of 166,949 on sale
2025-05-16BUY206757.390758.870 758.722EUR 156,297 826.96
2025-05-14BUY324715.560759.500 755.106EUR 244,654 828.56
2025-05-13BUY1,836746.060759.500 758.156EUR 1,391,974 829.21
2025-05-12SELL-108755.570765.330 764.354EUR -82,550 829.80 Profit of 7,068 on sale
2025-04-25BUY480884.540885.580 885.476EUR 425,028 830.71
2025-04-23SELL-214829.420846.010 844.351EUR -180,691 830.46 Loss of -2,973 on sale
2025-04-22SELL-1,070827.540832.000 831.554EUR -889,763 830.49 Loss of -1,142 on sale
2025-04-11BUY204732.410735.840 735.497EUR 150,041 833.69
2025-04-09BUY204753.710754.830 754.718EUR 153,962 835.56
2025-04-08SELL-515726.240763.500 759.774EUR -391,284 836.64 Profit of 39,584 on sale
2025-04-07SELL-729723.730748.000 745.573EUR -543,523 837.75 Profit of 67,200 on sale
2025-04-04BUY107738.210768.270 765.264EUR 81,883 838.75
2025-03-27BUY428821.670826.770 826.260EUR 353,639 839.80
2025-03-11BUY2,675824.060832.350 831.521EUR 2,224,319 841.11
2025-03-07BUY214869.580908.000 904.158EUR 193,490 840.90
2025-03-06BUY204912.760931.380 929.518EUR 189,622 840.00
2025-03-03SELL-408929.720935.630 935.039EUR -381,496 836.74 Loss of -40,104 on sale
2025-02-28SELL-2,540920.630921.220 921.161EUR -2,339,749 835.64 Loss of -217,222 on sale
2025-02-26BUY4,346915.010922.430 921.688EUR 4,005,656 833.63
2025-02-18SELL-3,024857.200862.730 862.177EUR -2,607,223 829.92 Loss of -97,558 on sale
2025-02-13BUY428871.860883.500 882.336EUR 377,640 828.83
2024-12-09BUY224803.580823.700 821.688EUR 184,058 829.85
2024-12-04SELL-560829.840846.460 844.798EUR -473,087 830.02 Loss of -8,277 on sale
2024-12-03SELL-2,464813.330817.130 816.750EUR -2,012,472 830.40 Profit of 33,625 on sale
2024-11-25SELL-1,752755.000755.000 755.000EUR -1,322,760 837.41 Profit of 144,383 on sale
2024-11-19SELL-110729.730730.000 729.973EUR -80,297 848.25 Profit of 13,011 on sale
2024-11-18SELL-115727.200734.000 733.320EUR -84,332 851.92 Profit of 13,639 on sale
2024-11-12BUY345818.860833.990 832.477EUR 287,205 852.95
2024-11-01SELL-920818.930833.000 831.593EUR -765,066 886.48 Profit of 50,493 on sale
2024-11-01SELL-920818.930833.000 831.593EUR -765,066 886.48 Profit of 50,493 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LLY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19432,0389351,319,85332.7%
2025-09-18547,8181261,290,14742.5%
2025-09-17437,3374271,166,20437.5%
2025-09-16532,6981,8291,463,37436.4%
2025-09-15424,9797011,071,48739.7%
2025-09-12267,121172826,80232.3%
2025-09-11249,8031,484850,46129.4%
2025-09-10415,4421,025989,00842.0%
2025-09-09559,8056671,270,80044.1%
2025-09-08856,0184,6821,937,44744.2%
2025-09-05679,2761,0501,405,23948.3%
2025-09-04337,49153982,75134.3%
2025-09-03214,691496766,15728.0%
2025-09-02430,4772,9771,131,90838.0%
2025-08-29357,538602889,50940.2%
2025-08-28433,6871,0991,113,56838.9%
2025-08-27860,7156,0091,681,35351.2%
2025-08-261,548,46012,1052,955,34852.4%
2025-08-25566,4543,5861,323,24942.8%
2025-08-22749,6151,9571,460,71351.3%
2025-08-21651,6392231,570,06741.5%
2025-08-20679,5542,6981,870,24136.3%
2025-08-19787,9099352,788,74028.3%
2025-08-18756,1431,0951,727,60343.8%
2025-08-151,814,7218363,422,26053.0%
2025-08-141,852,9405,3823,602,82951.4%
2025-08-131,254,2253,4732,774,10045.2%
2025-08-12990,1103,1902,845,89634.8%
2025-08-111,290,0631,6155,196,30224.8%
2025-08-082,448,706300,8706,239,83039.2%
2025-08-074,197,951489,61810,364,29440.5%
2025-08-06440,1441,1201,811,26224.3%
2025-08-05331,460921993,17833.4%
2025-08-04474,9051,4081,273,99537.3%
2025-08-01530,5697,1391,882,09828.2%
2025-07-31882,5063,6702,110,03041.8%
2025-07-30745,6143921,827,43540.8%
2025-07-291,081,8495712,607,24541.5%
2025-07-28304,8417,4601,004,03230.4%
2025-07-25365,4172651,055,27334.6%
2025-07-24321,7997621,167,14727.6%
2025-07-23485,7193,4711,044,91946.5%
2025-07-22241,0983,036874,71727.6%
2025-07-21418,0148541,180,44535.4%
2025-07-18623,4986511,225,33350.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.